Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 17784-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#17784-1-AP, RRID:AB_2283320
- Product name
- ORC6 antibody
- Antibody type
- Polyclonal
- Description
- ORC6 antibody (Cat. #17784-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Topoisomerase I Inhibition in ETV4-overexpressed Non-Small Cell Lung Cancer Promotes Replication and Transcription Mediated R-Loop Accumulation and DNA Damage.
Multi-omics analysis reveals the involvement of origin recognition complex subunit 6 in tumor immune regulation and malignant progression.
Development and validation of a novel prognostic signature in gastric adenocarcinoma.
The synthetic antihyperlipidemic drug potassium piperate selectively kills breast cancer cells through inhibiting G1-S-phase transition and inducing apoptosis.
Zhang J, Wang Y, Cao S, Xie SM, Liu B, Li Y, Hou Y, Meng X, Ruan M, Bu D, Kang J, Li R, Lou L, Wang J, Xing L
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2025 Sep;12(35):e09307
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2025 Sep;12(35):e09307
Multi-omics analysis reveals the involvement of origin recognition complex subunit 6 in tumor immune regulation and malignant progression.
Zhu J, Chen Q, Zeng L, Gao H, Wu T, He Y, Xu J, Pang J, Peng J, Deng Y, Han Y, Yi W
Frontiers in immunology 2023;14:1236806
Frontiers in immunology 2023;14:1236806
Development and validation of a novel prognostic signature in gastric adenocarcinoma.
Mao R, Wang Z, Zhang Y, Chen Y, Liu Q, Zhang T, Liu Y
Aging 2020 Nov 8;12(21):22233-22252
Aging 2020 Nov 8;12(21):22233-22252
The synthetic antihyperlipidemic drug potassium piperate selectively kills breast cancer cells through inhibiting G1-S-phase transition and inducing apoptosis.
Fan L, Cao X, Yan H, Wang Q, Tian X, Zhang L, He X, Borjihan G, Morigen
Oncotarget 2017 Jul 18;8(29):47250-47268
Oncotarget 2017 Jul 18;8(29):47250-47268
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Jurkat cells were subjected to SDS PAGE followed by western blot with 17784-1-AP(ORC6L antibody) at dilution of 1:800
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The ORC6 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human ORC6. This antibody recognizes human,mouse,rat antigen. The ORC6 antibody has been validated for the following applications: ELISA, WB, IHC analysis.
